---
$id: https://graph.org.ai/products/commodity/51111758
$type: Product
source: UNSPSC
code: "51111758"
title: "Panitumumab"
class: "51111700"
classTitle: "Antineoplastic antibiotics"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Panitumumab

**UNSPSC Code**: 51111758
**Class**: [Antineoplastic antibiotics](Antineoplastic antibiotics.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a monoclonal antibody with the molecular formula C6398H9878N1694O2016S48, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6A901E312A, more generally known as panitumumab. European Medicines Agency schedules panitumumab in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB25390. The term PANITUMUMAB is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19, no. 1, 2005, list 53. Most nations schedule Panitumumab under HS 30021091 and SITC 54163. SMILES:. As of Q4 2014, PANITUMUMAB remains the US FDA Preferred Term for this commodity. . Panitumumab bears US NLM identifiers UMLS ID C0879427 and NCI Concept Code C1857.

